<DOC>
	<DOC>NCT01310972</DOC>
	<brief_summary>Adjuvant Colon Cancer With ELOXatin®/5 FU Based Regimen: ACCELOX</brief_summary>
	<brief_title>Adjuvant Colon Cancer w/ ELOXatin®/5 FU Based Regimen: ACCELOX</brief_title>
	<detailed_description>It's a study of adjuvant colon carcinoma using ELOXatin/5-FU based chemotherapeutic regimen called ACCELOX as a definitive curative therapy.</detailed_description>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Patients with Adjuvant Colon Cancer Patients with diagnosis other than Colon Cancer.</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Adjuvant Colon Cancer</keyword>
</DOC>